Medical supply giant Medline’s (MDLN.O) shares rose 41 per cent above their offer price in their hotly anticipated New York debut on Wednesday, rounding out a strong year for US IPOs with volumes hitting their highest since 2021.
New listings made a strong comeback in 2025 after nearly three years of sluggish activity, buoyed by rate-cut hopes and a more supportive dealmaking backdrop.
Eye-popping first-day performances by heavyweights such as
